NEW YORK (GenomeWeb News) – Microbial biomarker technologies developer Second Genome has undertaken an initiative with American Gut, a multi-partner effort to characterize the microbial diversity of the gut, to study the possible roles the human microbiome may play in type 2 diabetes.

Under the initiative, Second Genome made a donation to American Gut of an undisclosed amount to fund specimen collection for participants who have type 2 diabetes, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.